MICROGESTIN 1/20 | Australian Register of Therapeutic Goods | Australia | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

MICROGESTIN 1/20
Australia

PharmaCompass Sponsored Ads

Contact Supplier

Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

Contact Supplier

pharmacompass-1-m-2026-01-12

PharmaCompass Sponsored Ads

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

pharmacompass-2-2026-02-09

MICROGESTIN 1/20

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

43 API Suppliers, 15 USDMF, 10 CEP/COS, 4 JDMF, 4 EU WC, 13 NDC API, 17 Listed Suppliers, $ API Reference Price

43 API Suppliers
15 USDMF
10 CEP/COS
4 JDMF
4 EU WC
13 NDC API
17 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

63 Drugs in Development

63 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1384 FDF Dossiers, 420 FDA Orange Book, 731 Europe, 108 Canada, 31 Australia, 60 South Africa, 34 Listed Dossiers

1384 FDF Dossiers
420 FDA Orange Book
731 Europe
108 Canada
31 Australia
60 South Africa
34 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL-28 - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-21 - 0.03MG;1.5MG, TABLET;ORAL-28 - 0.03MG;0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-21 - 0.03MG;1.5MG, TABLET;ORAL-21 - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-28 - 0.035MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.5MG,1MG,0.5MG, TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-28 - 0.035MG;0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-21 - 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-21 - 0.15MG;0.03MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.02MG,0.15MG;0.025MG,0.15MG;0.03MG,0.15MG;0.01MG,N/A, CAPSULE;ORAL - 0.02MG;1MG, TABLET, CHEWABLE, TABLET;ORAL - 0.01MG,0.01MG,N/A;1MG,N/A,N/A, TABLET;ORAL - 0.02MG;0.1MG, RING;VAGINAL - 0.013MG/24HR;0.15MG/24HR, TABLET;ORAL - 0.0025MG;0.5MG, TABLET;ORAL - 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-28 - 0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0.025MG, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.035MG/24HR;0.15MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, RING;VAGINAL - 0.015MG/24HR;0.12MG/24HR, TABLET;ORAL-28 - 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.035MG;0.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 3MG;0.02MG, TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.01MG,0.01MG;1MG,N/A, TABLET, CHEWABLE;ORAL - 0.025MG;0.8MG

TABLET;ORAL-28 - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL-21 - 0.03MG;1.5MG
TABLET;ORAL-28 - 0.03MG;0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL-21 - 0.03MG;1.5MG
TABLET;ORAL-21 - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL-28 - 0.035MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.5MG,1MG,0.5MG
TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL-28 - 0.035MG;0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL-21 - 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL-21 - 0.15MG;0.03MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 0.02MG,0.15MG;0.025MG,0.15MG;0.03MG,0.15MG;0.01MG,N/A
CAPSULE;ORAL - 0.02MG;1MG
TABLET, CHEWABLE, TABLET;ORAL - 0.01MG,0.01MG,N/A;1MG,N/A,N/A
TABLET;ORAL - 0.02MG;0.1MG
RING;VAGINAL - 0.013MG/24HR;0.15MG/24HR
TABLET;ORAL - 0.0025MG;0.5MG
TABLET;ORAL - 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL-28 - 0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0.025MG
FILM, EXTENDED RELEASE;TRANSDERMAL - 0.035MG/24HR;0.15MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
RING;VAGINAL - 0.015MG/24HR;0.12MG/24HR
TABLET;ORAL-28 - 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 0.035MG;0.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 3MG;0.02MG
TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 0.01MG,0.01MG;1MG,N/A
TABLET, CHEWABLE;ORAL - 0.025MG;0.8MG

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 5 SPI Pharma, 4 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Kirsch Pharma, 1 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 25 BASF, 2 Clariant, 11 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 1 Esteem Industries, 1 Finar, 8 Gangwal Chemicals, 5 Ideal Cures, 4 Ingredion Pharma Solutions, 26 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 23 Roquette, 7 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 5 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 5 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

58 Fillers, Diluents & Binders, 48 Coating Systems & Additives, 31 Disintegrants & Superdisintegrants, 31 Granulation, 30 Direct Compression, 26 Controlled & Modified Release, 23 Thickeners and Stabilizers, 20 Lubricants & Glidants, 16 Solubilizers, 15 Taste Masking, 13 Topical, 12 Co-Processed Excipients, 9 Film Formers & Plasticizers, 8 Chewable & Orodispersible Aids, 8 Parenteral, 7 API Stability Enhancers, 5 Empty Capsules, 5 Emulsifying Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents, 2 Coloring Agents

58 Fillers, Diluents & Binders
48 Coating Systems & Additives
31 Disintegrants & Superdisintegrants
31 Granulation
30 Direct Compression
26 Controlled & Modified Release
23 Thickeners and Stabilizers
20 Lubricants & Glidants
16 Solubilizers
15 Taste Masking
13 Topical
12 Co-Processed Excipients
9 Film Formers & Plasticizers
8 Chewable & Orodispersible Aids
8 Parenteral
7 API Stability Enhancers
5 Empty Capsules
5 Emulsifying Agents
5 Rheology Modifiers
4 Vegetarian Capsules
3 Surfactant & Foaming Agents
2 Coloring Agents

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 156 News #PharmaBuzz

2 Data Compilation #PharmaFlow
156 News #PharmaBuzz

GLOBAL SALES INFORMATION

143 US Medicaid Prescriptions, 45 Regulatory FDF Prices, 41 Annual Reports

143 US Medicaid Prescriptions
45 Regulatory FDF Prices
41 Annual Reports

MARKET PLACE

17 APIs, 3 FDF Dossiers, 1 EXCIPIENTS

17 APIs
3 FDF Dossiers
1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

31 US Patents, 1 US Exclusivities, 29 Health Canada Patents

31 US Patents
1 US Exclusivities
29 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 3 JP, 5 Others

3 EDQM
2 USP
3 JP
5 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 3,904 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

31 All

01 2AFT Pharmaceuticals (AU) Pty Ltd

02 1Alphapharm Pty Ltd

03 1Apotex Pty Ltd

04 11Arrotex Pharmaceuticals Pty Ltd

05 2Bayer Australia Ltd

06 5Generic Health Pty Ltd

07 1Organon

08 3Pfizer Australia Pty Ltd

09 4Sandoz Pty Ltd

10 1WAGNER PHARMACEUTICALS PTY LTD

filter Active Ingredients Reset all filters

31 All

01 16Drospirenone + ethinylestradiol

02 1Etonogestrel; Ethinylestradiol

03 12Levonorgestrel + ethinylestradiol

04 2Norethisterone + ethinylestradiol

filter Dosage Form Reset all filters

31 All

01 12Tablet

02 2Tablet; Tablet

03 17Blank

filter Brand Name Reset all filters

31 All

01 2Bella

02 1Eleanor 150/30 ED

03 1Evelyn 150/30 ED

04 1Femme-Tab ED 20/100

05 1Femme-Tab ED 30/150

06 2Isabelle

07 1LEVETH 150/30 ED

08 1Lenest 30 ED

09 1Levlen ED

10 1Logynon ED

11 1Microgynon 50 ED

12 1Micronelle 30 ED

13 1Norimin 28 Day

14 1Norimin-1 28 Day

15 1NuvaRing

16 2Rosalee

17 2Rosie

18 1Trifeme 28

19 1Triquilar ED

20 2YANA

21 2Yasmin

22 2Yaz

23 2Yelena

Symbiotec Ethinyl Estradiol

List of Suppliers

Product Main Page

01

AFT Pharmaceuticals (AU) Pty Ltd

Asia Pharma Expo

Not Confirmed

AFT Pharmaceuticals (AU) Pty Ltd

Asia Pharma Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Levonorgestrel + ethinylestradiol

Brand Name : Femme-Tab ED 30/150

Dosage Form : Tablet

Dosage Strength : 150MCG

Packaging : 4

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

AFT Pharmaceuticals (AU) Pty Ltd

Asia Pharma Expo

Not Confirmed

AFT Pharmaceuticals (AU) Pty Ltd

Asia Pharma Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Levonorgestrel + ethinylestradiol

Brand Name : Femme-Tab ED 20/100

Dosage Form : Tablet

Dosage Strength : 100MCG

Packaging : 4

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Alphapharm Pty Ltd

Asia Pharma Expo

Not Confirmed

Alphapharm Pty Ltd

Asia Pharma Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Levonorgestrel + ethinylestradiol

Brand Name : Lenest 30 ED

Dosage Form : Tablet

Dosage Strength : 150MCG

Packaging : 4

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Apotex Pty Ltd

Asia Pharma Expo

Not Confirmed

Apotex Pty Ltd

Asia Pharma Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Levonorgestrel + ethinylestradiol

Brand Name : Micronelle 30 ED

Dosage Form : Tablet

Dosage Strength : 150MCG

Packaging : 4

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Arrotex Pharmaceuticals Pty Ltd

Asia Pharma Expo

Not Confirmed

Arrotex Pharmaceuticals Pty Ltd

Asia Pharma Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Levonorgestrel + ethinylestradiol

Brand Name : Eleanor 150/30 ED

Dosage Form : Tablet

Dosage Strength : 150MCG

Packaging : 4

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Arrotex Pharmaceuticals Pty Ltd

Asia Pharma Expo

Not Confirmed

Arrotex Pharmaceuticals Pty Ltd

Asia Pharma Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Levonorgestrel + ethinylestradiol

Brand Name : Levlen ED

Dosage Form : Tablet

Dosage Strength : 150MCG

Packaging : 4

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Arrotex Pharmaceuticals Pty Ltd

Asia Pharma Expo

Not Confirmed

Arrotex Pharmaceuticals Pty Ltd

Asia Pharma Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Levonorgestrel + ethinylestradiol

Brand Name : Microgynon 50 ED

Dosage Form : Tablet

Dosage Strength : 125MCG

Packaging : 4

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Arrotex Pharmaceuticals Pty Ltd

Asia Pharma Expo

Not Confirmed

Arrotex Pharmaceuticals Pty Ltd

Asia Pharma Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Drospirenone + ethinylestradiol

Brand Name : Yaz

Dosage Form :

Dosage Strength :

Packaging : 3

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Arrotex Pharmaceuticals Pty Ltd

Asia Pharma Expo

Not Confirmed

Arrotex Pharmaceuticals Pty Ltd

Asia Pharma Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Drospirenone + ethinylestradiol

Brand Name : Yaz

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Arrotex Pharmaceuticals Pty Ltd

Asia Pharma Expo

Not Confirmed

Arrotex Pharmaceuticals Pty Ltd

Asia Pharma Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Drospirenone + ethinylestradiol

Brand Name : Yelena

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.